BioCryst

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade BioCryst 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BCRX

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. 

CEO
Charles K. Gayer
CEOCharles K. Gayer
Employees
580
Employees580
Headquarters
Durham, North Carolina
HeadquartersDurham, North Carolina
Founded
1986
Founded1986
Employees
580
Employees580

BCRX Key Statistics

Market cap
1.63B
Market cap1.63B
Price-Earnings ratio
-139.11
Price-Earnings ratio-139.11
Dividend yield
Dividend yield
Average volume
4.68M
Average volume4.68M
High today
$6.80
High today$6.80
Low today
$6.42
Low today$6.42
Open price
$6.61
Open price$6.61
Volume
3.29M
Volume3.29M
52 Week high
$11.31
52 Week high$11.31
52 Week low
$6.00
52 Week low$6.00

Stock Snapshot

The current BioCryst(BCRX) stock price is $6.55, with a market capitalization of 1.63B. The stock trades at a price-to-earnings (P/E) ratio of -139.11.

As of 2026-01-31, BioCryst(BCRX) stock has fluctuated between $6.42 and $6.80. The current price stands at $6.55, placing the stock +2.0% above today's low and -3.6% off the high.

The BioCryst(BCRX)'s current trading volume is 3.29M, compared to an average daily volume of 4.68M.

In the last year, BioCryst(BCRX) shares hit a 52-week high of $11.31 and a 52-week low of $6.00.

In the last year, BioCryst(BCRX) shares hit a 52-week high of $11.31 and a 52-week low of $6.00.

BCRX News

Simply Wall St 4d
Does Blackstone’s US$400 Million Deal and Astria Hires Change The Bull Case For BioCryst?

On January 23, 2026, BioCryst Pharmaceuticals entered into a US$400 million term loan agreement with Blackstone to fund a planned merger, related transaction co...

Does Blackstone’s US$400 Million Deal and Astria Hires Change The Bull Case For BioCryst?

Analyst ratings

100%

of 9 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own BCRX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.